MX2007003398A - Sulfonamidas y sus usos. - Google Patents

Sulfonamidas y sus usos.

Info

Publication number
MX2007003398A
MX2007003398A MX2007003398A MX2007003398A MX2007003398A MX 2007003398 A MX2007003398 A MX 2007003398A MX 2007003398 A MX2007003398 A MX 2007003398A MX 2007003398 A MX2007003398 A MX 2007003398A MX 2007003398 A MX2007003398 A MX 2007003398A
Authority
MX
Mexico
Prior art keywords
sulfonamides
formula
methods
aredescribed
compounds
Prior art date
Application number
MX2007003398A
Other languages
English (en)
Inventor
Andrew Napper
Jeffrey O Saunders
Original Assignee
Elixir Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elixir Pharmaceuticals Inc filed Critical Elixir Pharmaceuticals Inc
Publication of MX2007003398A publication Critical patent/MX2007003398A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compuestos de la formula (I), incluyendo metodos para elaborarlos y usarlos, se describen en la formula (I).
MX2007003398A 2004-09-27 2005-09-27 Sulfonamidas y sus usos. MX2007003398A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61370004P 2004-09-27 2004-09-27
PCT/US2005/034522 WO2006036932A2 (en) 2004-09-27 2005-09-27 Sulfonamides and uses thereof

Publications (1)

Publication Number Publication Date
MX2007003398A true MX2007003398A (es) 2007-05-21

Family

ID=36119517

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007003398A MX2007003398A (es) 2004-09-27 2005-09-27 Sulfonamidas y sus usos.

Country Status (7)

Country Link
US (1) US20080261970A1 (es)
EP (1) EP1797090A4 (es)
JP (1) JP2008514634A (es)
CN (1) CN101039942A (es)
CA (1) CA2579242A1 (es)
MX (1) MX2007003398A (es)
WO (1) WO2006036932A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572807B2 (en) 2005-06-09 2009-08-11 Bristol-Myers Squibb Company Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
US7579360B2 (en) 2005-06-09 2009-08-25 Bristol-Myers Squibb Company Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
US8119658B2 (en) 2007-10-01 2012-02-21 Bristol-Myers Squibb Company Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
JP5535931B2 (ja) * 2008-10-27 2014-07-02 武田薬品工業株式会社 二環性化合物
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
EP2241634A1 (en) * 2009-04-16 2010-10-20 Université Libre de Bruxelles Diagnostic method and tools to predict the effiacy of targeted agents against IGF-1 pathway activation in cancer
JP2013518085A (ja) 2010-02-01 2013-05-20 ノバルティス アーゲー ＣＲＦ−１受容体アンタゴニストとしてのピラゾロ［５，１ｂ］オキサゾール誘導体
WO2011092293A2 (en) 2010-02-01 2011-08-04 Novartis Ag Cyclohexyl amide derivatives as crf receptor antagonists
WO2011095450A1 (en) 2010-02-02 2011-08-11 Novartis Ag Cyclohexyl amide derivatives as crf receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2917511A (en) * 1958-01-30 1959-12-15 Merck & Co Inc Bicyclic-nitrogen-heterocyclic compounds
MY139563A (en) * 2002-09-04 2009-10-30 Bristol Myers Squibb Co Heterocyclic aromatic compounds useful as growth hormone secretagogues
WO2005097788A2 (en) * 2004-04-02 2005-10-20 Elixir Pharmaceuticals, Inc. Sulfonamides and uses thereof

Also Published As

Publication number Publication date
CA2579242A1 (en) 2006-04-06
WO2006036932A2 (en) 2006-04-06
JP2008514634A (ja) 2008-05-08
US20080261970A1 (en) 2008-10-23
EP1797090A4 (en) 2009-11-11
CN101039942A (zh) 2007-09-19
WO2006036932A3 (en) 2006-06-22
EP1797090A2 (en) 2007-06-20

Similar Documents

Publication Publication Date Title
MX2007003398A (es) Sulfonamidas y sus usos.
MX2007005932A (es) 1-alquinil-2-ariloxialquilamidas y su uso como fungicidas.
TW200600499A (en) Novel amido-substituted hydroxy-6-phenylphenanthridines
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
PL372926A1 (en) Piperidine-pyridazones and phthalazones as pde4 inhibitors
IN2014CN03629A (es)
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
MX2007006397A (es) Derivados de tetrahidropirano.
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
WO2005087724A3 (en) Sulphonylpyrroles as hdac inhibitors
MX2009005508A (es) Pirimidinas substituidas y su uso como moduladores de cinasas c-jun n-terminales.
SG153800A1 (en) Pharmaceutical compositions
MX2007005933A (es) Compuestos de acetamida como fungicidas.
MX2007005408A (es) Compuestos de aminoquinazolinas.
DE602005014628D1 (de) Embolie-teilchen
TW200624426A (en) BACE inhibitors
MX2010006143A (es) Azolilmetiloxiranos, su uso y agentes que lo contienen.
WO2006072612A3 (en) Triazolophthalazines as pde2- inhibitors
SE0301653D0 (sv) Novel compounds
SG148192A1 (en) Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents
MX2007002277A (es) Metodos para formar retinoides y usos de los mismos.
MX2007002917A (es) Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma.
UY28344A1 (es) Nuevos compuestos
PA8646301A1 (es) Inhibidores de la adenilato ciclasa soluble

Legal Events

Date Code Title Description
FA Abandonment or withdrawal